Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analyses
Kouya Shiraishi, Kazuki Kumada(Tohoku University), Nobuo Fuse(Tohoku University), Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences), Takahisa Kawaguchi(Kyoto University), Noriko Motoi(Tokyo National Hospital), Kimihiro Shimizu(Shinshu University), Yataro Daigo(The University of Tokyo), Sadaaki Takata(RIKEN Center for Integrative Medical Sciences), Fumihiro Tanaka(University of Occupational and Environmental Health Japan), Yuichiro Nishida(Saga University), Katsuya Tsuchihara(Chiba Cancer Center), Shinichi Toyooka(Okayama University Hospital), Shun‐ichi Watanabe(Tokyo National Hospital), Akiteru Goto(Akita University), Masahiro Torasawa(Juntendo University), Yasushi Goto(Tennessee Oncology), Kōichi Goto(National Cancer Center Hospital East), Daisuke Takayanagi(Showa University Hospital), Akira Saito(StaGen (Japan)), Atsushi Takano(Shiga University of Medical Science), Katsuhiro Masago(Aichi Cancer Center), Masahiro Tsuboi(National Cancer Center Hospital East), Masashi Kobayashi(Obayashi (Japan)), Taiki Yamaji, Satoshi Nishizuka(Iwate Medical University), Kazue Yoneda(University of Occupational and Environmental Health Japan), Takumi Yamaura(Fukushima Medical University), Takayuki Honda, Syuzo Kaneko(RIKEN Center for Advanced Intelligence Project), Maiko Matsuda(National Center For Child Health and Development), Hidehito Horinouchi(Tokyo National Hospital), Norie Sawada(National Cancer Center), Yohei Miyagi(Kanagawa Cancer Center), Tatsuya Yoshida(Juntendo University), Makoto Sonobe(Kyoto University Hospital), Motonobu Saito(Fukushima Medical University), Tomomi Aoi(RIKEN Center for Integrative Medical Sciences), Yuichiro Ohe(National Cancer Center), Atsushi Takahashi(Fukushima Medical University), Teruhiko Yoshida(Fukushima Medical University), Takaaki Mizuno, Daichi Maeda(Garvan Institute of Medical Research), Hiroyuki Suzuki(Kurume University), Hideo Kunitoh(Japanese Red Cross Medical Center), Yoko Shimada, Kazumi Tanaka(Gunma University Hospital), Shingo Matsumoto(National Cancer Center Hospital East), Hiromi Sakamoto(National Cancer Centre Japan), Megumi Hara(Saga University)
Cited by 4
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k